Impact of Dermatophytosis on the Quality of Life in Patients Attending a Tertiary Care Hospital, Karachi

  • Bahram Khan Khoso
  • Fakhur Uddin Department of Microbiology, BMSI, JPMC, Karachi
  • Wajid Hussain
  • Meeran Mohammad Omar Dashti
Keywords: Dermatophytoses, Dermatology Life Quality Index, Quality of Life, Tinea cruris.

Abstract

Abstract

Objectives: To determine the impact of dermatophytosis on quality of life (QoL) of patients at tertiary care hospital, Karachi.

Methods: The cross-sectional descriptive research was piloted in the Departments of Dermatology and Microbiology, Jinnah Postgraduate Medical Centre (JPMC) Karachi, a leading public tertiary care hospital during the July 2019 to December 2019. The patients <16 years aged were excluded from this study. The KOH (10%) wet mount was performed for fungal hyphae and spore observation in specimens. Quality of life was determined by dermatology life quality index (DLQI) scores and their association with different variables was evaluated by using t-test and Fisher test.

Results: A total of 300 dermatophytosis patients were analyzed. The majority of the patients were of no education category. The active age group (16-30 years) showing higher frequency (138; 46.0%) and followed by age group of 31-50 years (126; 42.0%)).  In present study DLQI score mean was 13.4 ± 7.3. Unexposed area was the main site 249 (83.0%). Dermatophytosis has effect on the quality of life (QoL) in majority (98.7%) of the patients. The DLQI score was significantly higher in unexposed and both sites involvement (P < 0.001). DLQI score was not affected by the age, sex, literacy, addiction and other demographic variables.

Conclusion: This study revealed that dermatophytosis has a significant impact on the quality of life (QoL) in these patients.

 

References

1. AL-Khikani FH. Dermatophytosis a worldwide contiguous fungal infection: Growing challenge and few solutions. Biomed Biotechnol Res J, 2020;4:117-22
2. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician, 2008;77:1415-20
3. AL-Janabi AA. Dermatophytosis: Causes, clinical features, signs and treatment. J Sympt Signs, 2014;3:200-3.
4. Rajagopalan, M., Inamadar, A., Mittal, A. et al. Expert Consensus on the Management of Dermatophytosis in India (ECTODERM India). BMC Dermatol, 18, 6 (2018). https://doi.org/10.1186/s12895-018-0073-1
5. Mushtaq S, Faizi N, Amin SS, Adil M. Mohammad Mohtashim1 Impact on quality of life in patients with dermatophytosis. Australas J Dermatol, 2020; 61(2): e184-e188. https://doi.org/10.1111/ajd.13191
6. Varshney AP, Gahalaut P, Pardal PK, Mishra N, Rastogi MK, Thapa M. Quality of life in patients with chronic dermatophytosis. Nepal J Dermatol, Venereol and Leprol, 2020;18(1):44-51. https://doi.org/10.3126/njdvl.v18i1.27249
7. Rajashekar TS, Nandigonnanavar S, Kuppuswamy SK, Madhavi GS. Dermatology life quality index in patients with persisting and recurrent dermatophytoses. Int J Res Dermatol, 2019;5(1):139-143. DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20190233
8. He Z, Marrone G, Ou A, Liu H, Ma L, Huang Y, Li Y, Sun L, Bai Y, Liu W, Zha X & Lu C. Factors affecting health-related quality of life in patients with skin disease: cross-sectional results from 8,789 patients with 16 skin diseases. Health Qual Life Outcomes, 2020, 18: 298. https://doi.org/10.1186/s12955-020-01542-6
9. Putri G, Lubis IA, Putra IB. Quality of life in onychomycosis patients at H. Adam Malik General Hospital, Medan - Indonesia, 2016. Bali Medical J, 2018;7(3): 712-716. DOI:10.15562/bmj.v7i3.998
10. Mcgowan K L. Specimen Collection, Transport, and Processing: Mycology. In V. James, C.C. Karen, J. H.James, L. L. Marie, & W. W. David (Eds), Manual of Clinical Microbiology (10th ed., Vol. 1, pp. 1945 and1949 ). Washington, USA: ASM, 2011
11. Lindsley MD, Snyder JW, Atlas RM, Larocco MT. Reagents, Stains, and Media: Mycology. In V. James, C.C. Karen, J. H.James, L. L. Marie, & W. W. David (Eds), Manual of Clinical Microbiology (10th ed., Vol. 1, pp. 1951 ). Washington, USA: ASM, 2011.
12. Smidt AC, Lai J-S, Cella D, Patel S, Mancini AJ, Chamlin SL. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010 146(8):865-9. doi: 10.1001/archdermatol.2010.161.
13. Basra MKA, Chowdhury MMU, Smith EV, Freemantle N, Piguet V. A review of the use of the dermatology life quality index as a criterion in clinical guidelines and health technology assessments in psoriasis and chronic hand eczema. Dermatol Clin, 2012;30(2):237-44 doi: 10.1016/j.det.2011.11.002.
14. Hosthota A, Gowda T, Manikonda R. Clinical profile and risk factors of dermatophytoses: a hospital based study. Int J Res Dermatol, 2018;4(4):508-513
15. Shujat U, Ikram A, Abbasi SA, Ayyub M, Mirza IA, and Fayyaz M. Spectrum of Superficial and Deep Fungal Isolates in Northern Pakistan. Virol & Mycol, 2014, 3(2): 131. doi:10.4172/2161-0517.1000131
16. Hussain A, Zakki SA, Qureshi R. Epidemiological Study Of Dermatophytosis In Okara, Pakistan. RADS-JPPS, 2016; 4(1):184-187
17. Sharma R, Adhikari L, Sharma RL. Recurrent dermatophytosis: A rising problem in Sikkim, a Himalayan state of India. Indian J Pathol Microbiol, 2017;60:541-5
Published
2022-03-31
How to Cite
1.
Khoso B, Uddin F, Hussain W, Dashti MM. Impact of Dermatophytosis on the Quality of Life in Patients Attending a Tertiary Care Hospital, Karachi. JRMC [Internet]. 31Mar.2022 [cited 27May2022];26(1):128-32. Available from: https://journalrmc.com/index.php/JRMC/article/view/1850